Aeglea BioTherapeutics

0 followers

‌

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Headquarters

Employees

Links

Org chart

Russell J. Cox

Chief Executive Officer, Epirium Bio

Russell J. Cox

Collapse

Cortney Caudill

Chief Product Officer

Eric Bradford

Chief Development Officer

Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Teams

Leadership Team

0 members

Board of Directors

3 members

CEO and Executive Team

0 members

Similar companies

MindMed

4 followers

Insense

49 followers

Vertex Pharmaceuticals

36 followers

Gilead Sciences

92 followers

Pfizer

361 followers

Discover companies